Evidence map›Paper›PMID 17400784›Full record

ArticleApplied and environmental microbiology2007

Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans.

Martina Bielaszewska, Rita Prager, Robin Köck, Alexander Mellmann, Wenlan Zhang, Helmut Tschäpe, Phillip I Tarr, Helge Karch

Open access · greenAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 189 citations in OpenAlex.

  1. Surveillance of enteropathogenicJournal of medical microbiology · 2026
    Article
  2. Article
  3. Article
  4. Emerging hybrid shigatoxigenic and enteropathogenicClinical microbiology reviews · 2025
    Review
  5. Article
  6. Intestinal Carriage of Two DistinctPathogens (Basel, Switzerland) · 2024
    Article
  7. DiarrheagenicInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review ofInfection and drug resistance · 2022
    Review
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Martina BielaszewskaInstitute for Hygiene and the National Consulting Laboratory on Hemolytic Uremic Syndrome, University of Münster, Germany. mbiela@uni-muenster.de
Rita Prager
Robin Köck
Alexander Mellmann
Wenlan Zhang
Helmut Tschäpe
Phillip I Tarr
Helge Karch
University of Münster · DERobert Koch Institute · DEWashington University in St. Louis · US

Funding

EVOLUTION OF VIRULENCE BY GENE ACQUISITIONR01AI047499 · NIAID · WASHINGTON UNIVERSITY · PI TARR, PHILLIP I · 1999 to 2002
$1.1M
NIAID NIH HHS AI47499NIAID NIH HHS R01 AI047499
6 · The paper itself

Abstract

Escherichia coli serogroup O26 consists of enterohemorrhagic E. coli (EHEC) and atypical enteropathogenic E. coli (aEPEC). The former produces Shiga toxins (Stx), major determinants of EHEC pathogenicity, encoded by bacteriophages; the latter is Stx negative. We have isolated EHEC O26 from patient stools early in illness and aEPEC O26 from stools later in illness, and vice versa. Intrapatient EHEC and aEPEC isolates had quite similar pulsed-field gel electrophoresis (PFGE) patterns, suggesting that they might have arisen by conversion between the EHEC and aEPEC pathotypes during infection. To test this hypothesis, we asked whether EHEC O26 can lose stx genes and whether aEPEC O26 can be lysogenized with Stx-encoding phages from EHEC O26 in vitro. The stx2 loss associated with the loss of Stx2-encoding phages occurred in 10% to 14% of colonies tested. Conversely, Stx2- and, to a lesser extent, Stx1-encoding bacteriophages from EHEC O26 lysogenized aEPEC O26 isolates, converting them to EHEC strains. In the lysogens and EHEC O26 donors, Stx2-converting bacteriophages integrated in yecE or wrbA. The loss and gain of Stx-converting bacteriophages diversifies PFGE patterns; this parallels findings of similar but not identical PFGE patterns in the intrapatient EHEC and aEPEC O26 isolates. EHEC O26 and aEPEC O26 thus exist as a dynamic system whose members undergo ephemeral interconversions via loss and gain of Stx-encoding phages to yield different pathotypes. The suggested occurrence of this process in the human intestine has diagnostic, clinical, epidemiological, and evolutionary implications.

Indexed as

Gene Transfer, HorizontalBacteriophagesCluster AnalysisDNA, BacterialDNA, ViralElectrophoresis, Gel, Pulsed-FieldEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsFecesHumansProphagesRecombination, GeneticShiga ToxinsVirulence FactorsDNA, BacterialDNA, ViralEscherichia coli ProteinsShiga ToxinsVirulence Factors

Identifiers

PMID17400784
PMCPMC1907125
OpenAlexW2137776373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.